Real-world outcomes of rituximab- and cyclophosphamide-based induction therapy regimens alone and in combination over 24 months in ANCA-associated vasculitis
RTX alone was similarly effective to RTX/CYC combination and CYC-AZA therapy in AAV patients, including those with severe renal involvement.
Authors
- Martin Nitschke (ORCID: https://orcid.org/0000-0002-2716-7527)
- Gabriela Riemekasten (ORCID: https://orcid.org/0000-0002-5406-2464)
- Peter Lamprecht (ORCID: https://orcid.org/0000-0001-5929-868X)
- Stephan Christian Werth
- Hanna Graßhoff
- Sebastian Klapa (ORCID: https://orcid.org/0000-0002-0012-0163)
- Diamant Thaçi (ORCID: https://orcid.org/0000-0001-8513-550X)
- Katja von Allwörden
- Antje Müller
- Anja Leheis
Institutions
- Christian-Albrechts-Universität zu Kiel (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2025-02-07
- DOI
- https://doi.org/10.55563/clinexprheumatol/cfyh9p
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca
- Bundesministerium für Bildung und Forschung
- Universität zu Lübeck
- Vifor Pharma